[Drug-induced megaloblastic anemia].
D000437:Alcoholism / Q000150:complications*; D000748:Anemia, Macrocytic / Q000139:chemically induced*; D000749:Anemia, Megaloblastic / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions; D005493:Folic Acid Antagonists / Q000494:pharmacology; D006801:Humans; D008286:Malabsorption Syndromes / Q000139:chemically induced; D011739:Pyrimethamine / Q000009:adverse effects; D014223:Triamterene / Q000009:adverse effects; D014295:Trimethoprim / Q000009:adverse effects; D014805:Vitamin B 12 / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000964:Antimetabolites, Antineoplastic; D003276:Contraceptives, Oral; D005493:Folic Acid Antagonists; D014295:Trimethoprim; D014805:Vitamin B 12; D014223:Triamterene; D011739:Pyrimethamine
Medikamentös bedingte megaloblastische Anämien.